Evidence map›Paper›PMID 14997286›Full record

Trial reportOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2004

Randomized controlled trial of hip protectors among women living in the community.

Yvonne F Birks, Jill Porthouse, Caroline Addie, Karen Loughney, Lucy Saxon, Mike Baverstock, Roger M Francis, David M Reid, Ian Watt, David J Torgerson and 1 more

Abstract readClinical TrialRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 7 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 7 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Pooled it
  2. Hip protectors for preventing hip fractures in older people.The Cochrane database of systematic reviews · 2014
    Pooled it
  3. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2007
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2005
    Pooled it
  7. Methodological bias in cluster randomised trials.BMC medical research methodology · 2005
    Pooled it
  8. Increasing adherence with the use of hip protectors for older people living in the community.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Trial
  9. External hip protectors are effective for the elderly with higher-than-average risk factors for hip fractures.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2009
    Trial
  10. Trial
  11. Trial
  12. Review
  13. Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Article
  14. Hip protectors: recommendations for conducting clinical trials--an international consensus statement (part II).Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2010
    Article
  15. The health-related quality of life and cost implications of falls in elderly women.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2009
    Article
  16. The pathophysiology of osteoporotic hip fracture.McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students · 2008
    Article
  17. Article
  18. Review
  19. Review
  20. Reporting attrition in randomised controlled trials.BMJ (Clinical research ed.) · 2006
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yvonne F BirksPrimary Care Hip Protector Trial Group, York Trials Unit, Department of Health Sciences, York University, Area 4, Seebhom Rowntree Building, YO10 5DD, UK.
Jill Porthouse
Caroline Addie
Karen Loughney
Lucy Saxon
Mike Baverstock
Roger M Francis
David M Reid
Ian Watt
David J Torgerson
Primary Care Hip Protector Trial Group
University of York · GBFreeman Hospital · GBUniversity of Aberdeen · GBWoolmanhill Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess whether hip protectors used among women living in the community in the United Kingdom and at high risk of hip fracture, lead to a reduction in hip fracture.

designPragmatic randomized controlled trial (RCT).

settingPrimary care with participants being recruited largely from general practitioners' patient lists.

participantsWomen aged 70 years and over with one or more risk factors for hip fracture (i.e., low body weight, current smoker, a prior fracture, family history of hip fracture).

interventionThree pairs of hip protectors of the "shell" type mailed to participants with instructions on how to use them.

main outcome measureReduction in hip fractures.

results1,388 and 2,781 women aged 70 years or over were randomized to be given three pairs of hip protectors or act as controls, respectively. We followed up both groups of women for a minimum of 24 months (maximum 42 months, median 28). Compliance was poor with only 31% of participants reporting that they wore the hip protectors on a daily basis at 12 months. Intention-to-treat analysis showed that there was no statistically significant difference in the unadjusted odds ratios (ORs) of sustaining a hip fracture between the groups (OR = 1.19; 95% confidence interval, 0.80 to 1.78, p = 0.40). Adjustment for important covariates did not materially change these findings (OR = 1.17; 95% CI, 0.78 to 1.75). Comparing the rate of hip fracture between those women who regularly wore the devices and the control group yielded an OR of 1.12 (95% CI, 0.58 to 2.03; p = 0.83).

conclusionThis study is the largest RCT of hip protectors to date and provides no evidence of an effect of hip protectors among women living independently and at high risk of fracture.

Indexed as

Protective DevicesAccidental FallsAgedEquipment DesignFemaleHip FracturesHumansIncidenceOsteoporosisPatient CompliancePrimary Health CareRisk FactorsTreatment OutcomeUnited Kingdom

Identifiers

PMID14997286
OpenAlexW2000211965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.